Federal regulators invite industry, researchers, and lobbyists to closed-door meetings on clinical AI - STAT

Federal health regulators are meeting with AI companies and researchers to set rules for how AI can be used in clinical medicine. These decisions will determine what medical AI tools doctors can use.